diphenyleneiodonium has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Werlenius, O | 1 |
| Riise, RE | 1 |
| Simpanen, M | 1 |
| Aurelius, J | 1 |
| Thorén, FB | 1 |
1 other study available for diphenyleneiodonium and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
CD20 antibodies induce production and release of reactive oxygen species by neutrophils.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; A | 2014 |